Circulating Biomarkers World Congress 2016

Date: Monday, 21 March 2016 - Tuesday, 22 March 2016
Location: Boston, USA

Keynote Speakers

Shana Kelley
Professor, University of Toronto

Joshua Levin
Senior Group Leader, Research Scientist, Stanley Center for Psychiatric Research, Klarman Cell Observatory, The Broad Institute of MIT and Harvard

Chwee Teck Lim
NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore

Phil Stephens
Chief Scientific Officer, Foundation Medicine

Peter Quesenberry
Professor of Medicine, The Warren Alpert Medical School of Brown University

John Palma
Chief Medical Officer, Roche Sequencing Solutions

Clark Chen Co-Director, University of California-San Diego	Xandra Breakefield Professor, Mass General Hospital (MGH)/Harvard Medical School	Gyongyi Szabo Professor & Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School	Bob Carter Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School	Shannon Stott Assistant Professor, Massachusetts General Hospital & Harvard Medical School	Stefan Momma Group Leader, University Hospital Frankfurt
Frank Slack Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School	Saumya Das Assistant Professor in Medicine, Beth Israel Deaconess Medical Center and Mass General Hospital	Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

Overview

The 3^rd. Annual SELECTBIO Circulating Biomarkers World Congress 2016 brings together academic researchers as well as industry participants to present and discuss the most up-to-date research and commercial activities in the translation of various circulating biomarker classes towards the clinic.

This Congress discusses Nucleic Acid-based Biomarkers, Protein-based Biomarkers, Extracellular Vesicle (EV)-based Biomarkers (contained within exosomes and microvesicles), and Circulating Tumor Cell (CTC)-based Biomarkers.

Download Links

Liquid Biopsy Slide Deck

Exosomes Market Analysis Slide Deck

One of the conference tracks focuses on Liquid Biopsies as the fields of Circulating Biomarkers and Liquid Biopsy development are converging and the various classes of Circulating Biomarkers may be developed into liquid biopsies for cancer and several other disease classes.

A co-located exhibit hall features companies developing technologies and products for the complete workflow from sample isolation, preparation, through data analysis.

Conference delegates receive access to all three co-located conference tracks, can mix-and-match presentations from all three tracks thereby maximizing the conference experience, and can network with delegates from the various co-located tracks and exhibition.

Agenda and Information for: Exosomes and Microvesicles: Research, Biomarker Cargo and Therapeutic Potential 21 Mar - 22 Mar 2016 Circulating DNA, Circulating RNA, Circulating Tumor Cells, Circulating Proteins 21 Mar - 22 Mar 2016 RNA-Seq, Digital PCR, and Liquid Biopsies: Capturing Value from Circulating Biomarkers 21 Mar - 22 Mar 2016

Corporate Sponsors	Media Sponsors	Top Media Partner Media Sponsors Media Sponsors	Networking

Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonCirculating Biomarkers World Congress 2016Circulating Biomarkers World Congress 2016 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

#CBWC2016 Tweets

Corporate Sponsors

Circulating Biomarkers World Congress 2016

Date: Monday, 21 March 2016 - Tuesday, 22 March 2016Location: Boston, USA

Keynote Speakers

Overview

Agenda and Information for:

Date: Monday, 21 March 2016 - Tuesday, 22 March 2016
Location: Boston, USA